title: Reports of equivalence trials should not mask negative or mediocre results.
authors.forename: M
authors.initials: M
authors.lastname: Lequesne
authors.forename: M
authors.initials: M
authors.lastname: Samson
mesh_terms: D000700:Analgesics / Q000493:pharmacokinetics*; D000880:Anthraquinones / Q000493:pharmacokinetics*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D006027:Glycosides; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy*; D011714:Pyrans / Q000493:pharmacokinetics*; D013810:Therapeutic Equivalency
chemical_list: D000700:Analgesics; D000880:Anthraquinones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006027:Glycosides; D011714:Pyrans; C025292:diacerein; C033249:harpagoside